Storia in 6 fonti

Weight-loss jabs could cut breast cancer risk by nearly a third

Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

dailymail.comStai leggendo1 mesi fa

Weight-loss jabs could cut breast cancer risk by nearly a third

Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.

originale

theguardian.com1 mesi fa

Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

Leggi questa versione → originale

euronews.com1 mesi fa

Weight-loss drugs linked to lower breast cancer risk, study finds

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.

Leggi questa versione → originale

independent.co.uk1 mesi fa

GLP-1s may lower breast cancer risk in women by 30%, new study suggests

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity (Alamy/PA) (Alamy/PA)A new study from the…

Leggi questa versione → originale

sciencedaily.com1 mesi fa

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but…

Leggi questa versione → originale

newsbytesapp.com1 mesi fa

Weight loss drugs can protect you from breast cancer

Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.

Leggi questa versione → originale

Timeline cronologica

lunedì 1 giugno 2026·sciencedaily.com
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…
martedì 2 giugno 2026·theguardian.com
Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest
Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease
martedì 2 giugno 2026·dailymail.com
Weight-loss jabs could cut breast cancer risk by nearly a third
Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.
martedì 2 giugno 2026·independent.co.uk
GLP-1s may lower breast cancer risk in women by 30%, new study suggests
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity…
mercoledì 3 giugno 2026·newsbytesapp.com
Weight loss drugs can protect you from breast cancer
Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.
giovedì 4 giugno 2026·euronews.com
Weight-loss drugs linked to lower breast cancer risk, study finds
Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.